Latest Dendreon Stories
VANCOUVER, British Columbia, Jan. 6, 2012 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: Citigroup (NYSE:C), Dendreon (NASDAQ:DNDN), Wells Fargo (NYSE:WFC), POWRtec (OTC:POWT), Cisco (NASDAQ:CSCO) and Eli Lilly (NYSE:LLY). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights:...
WORCESTER, Mass. and TORONTO, Jan. 4, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT) announced today that representatives of the Company's wholly-owned subsidiary, Antigen Express, Inc., will be in attendance at the 2012 JPMorgan Healthcare Conference in San Francisco from January 8 through 13. (Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b ) Representatives of Antigen Express will be available over the course of the conference to meet with...
WORCESTER, Mass. and TORONTO, Dec. 19, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB:GNBT.OB) today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc. The segment is scheduled to air at 6 pm EST (3 pm PST) today, Monday, December 19, 2011 (see promo at http://i879.photobucket.com/albums/ab357/tc2000chartreader/72389a92.mp4. It is...
VANCOUVER, British Columbia, Nov. 22, 2011 /PRNewswire-Asia/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: NVIDIA (NASDAQ:NVDA), Macy's (NYSE:M), Dendreon (NASDAQ:DNDN), Spreadtrum (NASDAQ:SPRD), Inhibitex (NASDAQ:INHX) & AMWEST IMAGING (OTC:AMWI). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...
VANCOUVER, British Columbia, Nov. 18, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: High Plains Gas (OTC:HPGS), Dendreon (NASDAQ:DNDN), Comcast (NASDAQ:CMCSA), JetBlue Airways (NASDAQ:JBLU), MEDINAH MINERALS (PINK:MDMN) & CANADIAN OIL SANDS (PINK:COSWF). (Logo: http://photos.prnewswire.com/prnh/20110914/HK68141LOGO ) One way to find hot penny stocks out of the over 8,000 penny stocks listed on...
SEATTLE, Oct. 17, 2011 /PRNewswire/ - Christopher Henney, Chairman of the Board of Oncothyreon Inc. (Nasdaq: ONTY) and of Anthera Pharmaceuticals (Nasdaq: ANTH) and Vice Chairman of the Board of Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC), received this year's Hall of Fame - special recognition of outstanding individual contributions award at the annual Biotech CEO Meeting at Laguna Beach. Henney, the co founder of Immunex, ICOS and Dendreon corporations was recognized for his...
CHICAGO, Oct. 4, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Bayer (OTC: BAYRY), Dendreon (Nasdaq: DNDN), PACCAR Inc. (Nasdaq: PCAR), Volvo (OTC: VOLVY) and Daimler (OTC: DDAIF). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Get the most recent insight from Zacks...
EMERYVILLE, Calif., Oct. 3, 2011 /PRNewswire/ -- Redwood Bioscience, a biopharmaceutical company developing a rational protein-chemical design technology for optimizing drug conjugates, announced the appointment of Peter Van Vlasselaer, PhD as Executive Chairman to Redwood's Board of Directors. In this role, Dr. Van Vlasselaer will be actively guiding Redwood on drug and platform development as well as corporate strategy. Dr. Van Vlasselaer has been involved in the start-up of four...
ALLENDALE, N.J., LOS ANGELES and WOODLAND HILLS, Calif., Oct. 3, 2011 /PRNewswire/ -- Progenitor Cell Therapy, LLC ("PCT"), an internationally recognized cell therapy services and development company and a wholly-owned subsidiary of NeoStem, Inc. (NYSE Amex: NBS), and ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) ("IMUC"), a clinical-stage biotechnology company that is focused on developing new immune-based products to treat and diagnose cancer, announced today that IMUC has retained the...
THE WOODLANDS, Texas, Sept. 30, 2011 /PRNewswire/ -- David, a 67-year-old father of three and soon to be first-time grandfather, felt too young to be diagnosed with prostate cancer. "I felt great," he said. "I had no symptoms." David, under the advisement of his oncologist, decided to be treated with PROVENGE® (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies. (Logo: http://photos.prnewswire.com/prnh/20110916/MM70140LOGO) "Being treated...
